Transforming growth factor β1 and soluble Fas serum levels in hepatocellular carcinoma

Cytokine

Volumn 12, Issue 6, 2000, Pages 811-814

  Sacco, Rodolfo ^a   Leuci, Domenico ^a   Tortorella, Cosimo ^a   Fiore, Giorgio ^a   Marinosci, Felice ^a   Antonaci, Salvatore ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Cirrhosis; HCC; Soluble Fas; Transforming growth factor 1; Tumour markers

Indexed keywords

ALPHA FETOPROTEIN; FAS ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0033948531     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0650     Document Type: Article

References (9)

1. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, Coderc E, Reboullet P, Beaugrand M. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 20:1994;65-71.
2. Tsai JF, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Frequency of raised AFP level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br J Cancer. 69:1994;1157-1159.
3. Cross MC, Dexter TM. Growth factors in development transformation and tumorigenesis. Cell. 64:1991;271-280.
4. Fausto N, Mead JE, Gruppuso PA, Brown L. TGF-beta in liver development, regeneration and carcinogenesis. Ann NY Acad Sci. 593:1991;231-242.
5. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L. Involvement of CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med. 182:1995;1223-1230.
6. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiafer MC, Barr PJ, Mountz JD. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
7. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
8. Castilla A, Prieto J, Fausto N. The transforming growth factor β1 and α in chronic liver disease: effect of interferon alpha therapy. N Engl J Med. 323:1991;933-940.
9. Ito N, Kawata S, Tamura S, Takaishi K, Yabuuchi Y, Matsuda Y, Nishiora M, Tarui S. Expression of Transforming growth factor β1 mRNA in human hepatocellular carcinoma. Jpn J Cancer Res. 81:1990;1202-1205.